Skip to main content

Unable to load price data. Sorry.


Covance, Inc. (NYSE:CVD.DL)

CAPS Rating: No stars

A drug development services company providing a range of early stage and late stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries.

Unable to load market data for this Ticker. Sorry.



This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform

All-Star Players

0 Outperform
0 Underperform

Wall Street

0 Outperform
0 Underperform

Top NYSE:CVD.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

EldrehadsPicks (< 20)
Submitted February 29, 2008

Let’s face it, investing in drug developers isn’t easy. First, there’s the science risk – the chance that the company’s best drug prospect will fail somewhere during the arduous clinical trial and regulatory approval process. If that weren’t enough,… More

epumple (< 20)
Submitted June 26, 2008

Covance is notorious for its cruel treatment of its laboratory animals and is the subject of a major campaign by Peta. Unlike most industries that use animals, Covance has been totally resistant to negotiation on this issue. I believe this is a sign… More


  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about CVD.DL.

No one has written a Pitch for CVD.DL stock yet. Tell us why you think CVD.DL will outperform or underperform against the market.


Find the members with the highest scoring picks in CVD.DL.

No players have picked CVD.DL yet. Tell us why you think CVD.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CVD.DL.